Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T-cell Lymphoblastic Lymphoma Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05487651
What this trial is testing

Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies

Who this might be right for
NHL, Relapsed, AdultB-cell LymphomaB-cell Leukemia+4 more
Athenex, Inc. 36
Very early researchNot Yet RecruitingNCT07335094
What this trial is testing

A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy

Who this might be right for
B Lymphoblastic Leukemia/Lymphoma
Zhujiang Hospital 60
Early research (Phase 1)Study completedNCT00275080
What this trial is testing

Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Early research (Phase 1)UnknownNCT05576181
What this trial is testing

Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
Fundamenta Therapeutics, Ltd. 19
Not applicableWithdrawnNCT00770419
What this trial is testing

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more
Rutgers, The State University of New Jersey
Early research (Phase 1)Looking for participantsNCT06208735
What this trial is testing

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

Who this might be right for
B-Cell LeukemiaNon-Hodgkin's LymphomaB-cell Acute Lymphoblastic Leukemia+5 more
British Columbia Cancer Agency 24
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT01424982
What this trial is testing

Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete Remission+4 more
M.D. Anderson Cancer Center 88
Testing effectiveness (Phase 2)Looking for participantsNCT05909059
What this trial is testing

CAR T-cell Therapy in Patients With Renal Dysfunction

Who this might be right for
Non-hodgkin Lymphoma,B CellMultiple MyelomaAcute Lymphoblastic Leukemia, Adult
Northside Hospital, Inc. 20
Early research (Phase 1)UnknownNCT03064269
What this trial is testing

CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia

Who this might be right for
B-cell Acute Lymphocytic Leukemia
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd 10
Early research (Phase 1)UnknownNCT04480788
What this trial is testing

CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study

Who this might be right for
T Lymphoblastic Leukemia/LymphomaExtramedullary NK-T-cell Lymphoma, Nasal TypePeripheral T-cell Lymphoma, Nonspecific+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 9
Early research (Phase 1)Active Not RecruitingNCT03233854
What this trial is testing

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

Who this might be right for
B Acute Lymphoblastic LeukemiaCD19 PositiveMinimal Residual Disease+1 more
Stanford University 56
Large-scale testing (Phase 3)Not Yet RecruitingNCT07754682
What this trial is testing

Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell Lymphoma

Who this might be right for
Chimeric Antigen Receptor T-cell TherapyB Cell Acute Lymphoblastic Leukemia (B-ALL)B Cell Lymphoma+2 more
Assistance Publique - Hôpitaux de Paris 228
Early research (Phase 1)Not Yet RecruitingNCT06641024
What this trial is testing

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoblastic Leukemia
Chongqing Precision Biotech Co., Ltd 24
Testing effectiveness (Phase 2)Study completedNCT00002673
What this trial is testing

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)WithdrawnNCT01162031
What this trial is testing

Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia

Who this might be right for
LeukemiaAcute Lymphocytic Leukemia
Stanford University
Testing effectiveness (Phase 2)Ended earlyNCT01621477
What this trial is testing

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelocytic LeukemiaChronic Myelocytic Leukemia+4 more
St. Jude Children's Research Hospital 34
Testing effectiveness (Phase 2)Looking for participantsNCT07072494
What this trial is testing

CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study

Who this might be right for
Acute Lymphoblastic Leukemia
Zhujiang Hospital 30
Next Page